Researchers at the University of Colorado Anschutz tied post-herpetic neuralgia (PHN) to circulating exosomes, reporting in Annals of Neurology that exosomes from PHN patients can trigger harmful neuronal dysfunction in lab models. The study supports a “failure-to-resolve” model where inflammation signals persist after viral clearance. Investigators led by Andrew Bubak, PhD found that exosomes from PHN patients induced changes in healthy nerve cells resembling those seen during viral infection, despite the absence of virus. The work points to circulating exosome cargo as a previously underreported mechanistic contributor and a potential therapeutic target. For the clinical pipeline, the study creates a new biomarker and drug intervention angle for PHN risk prediction and treatment development—moving beyond the conventional assumption that nerve damage from the initial shingles episode fully explains lingering pain.